Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERIC-GTN: RIPC and Glyceryl Trinitrate in Cardiac Surgery
NCT01864252Phase 3Completed
- Sponsor
- University College London
- Start
- Jan 2014
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nitroglycerin in myocardial reperfusion injury (4 arms), sponsored by University College London. Primary endpoint: Troponin T area under the curve at 72 hours. Started Jan 2014; status: completed.
02
Drugs
nitroglycerin
03
Conditions
myocardial reperfusion injury
Beyond the preview
Go deeper on NCT01864252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01864252.